Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:THRN

Thorne HealthTech (THRN) Stock Price, News & Analysis

Thorne HealthTech logo

About Thorne HealthTech Stock (NASDAQ:THRN)

Key Stats

Today's Range
$10.19
$10.19
50-Day Range
$10.13
$10.20
52-Week Range
$3.41
$10.20
Volume
N/A
Average Volume
110,986 shs
Market Capitalization
$549.44 million
P/E Ratio
26.82
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

Receive THRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thorne HealthTech and its competitors with MarketBeat's FREE daily newsletter.

THRN Stock News Headlines

Dr. Gary A. Thorne
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Lisa D. Thorne
Dr. Doris K. Thorne
See More Headlines

THRN Stock Analysis - Frequently Asked Questions

Thorne HealthTech, Inc. (NASDAQ:THRN) released its quarterly earnings results on Wednesday, November, 10th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.03. The company had revenue of $48.01 million for the quarter. Thorne HealthTech had a net margin of 7.84% and a trailing twelve-month return on equity of 9.03%.

Thorne HealthTech (THRN) raised $98 million in an initial public offering (IPO) on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Thorne HealthTech investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), e.l.f. Beauty (ELF), Arista Networks (ANET), Disc Medicine (IRON) and Jabil (JBL).

Company Calendar

Last Earnings
11/10/2021
Today
12/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
Current Symbol
NASDAQ:THRN
Fax
N/A
Employees
544
Year Founded
N/A

Profitability

Net Income
$15.67 million
Pretax Margin
5.59%

Debt

Sales & Book Value

Annual Sales
$228.73 million
Cash Flow
$0.26 per share
Book Value
$2.78 per share

Miscellaneous

Free Float
13,480,000
Market Cap
$549.44 million
Optionable
Optionable
Beta
0.82

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NASDAQ:THRN) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners